Influence of pregnancy on clinical course and fetal outcome of women with hypertrophic cardiomyopathy;Influência da gestação na evolução clínica materno-fetal de portadoras de cardiomiopatia hipertrófica

Arquivos Brasileiros de Cardiologia

Volumn 88, Issue 4, 2007, Pages

  Avila, Walkiria Samuel ^a,b   Amaral, Florence M Cavalcanti ^a   Ramires, Jose Antonio Franchini ^a   Rossi, Eduardo Giusti ^a   Grinberg, Max ^a   Bortolotto, Maria Rita Lemos ^a   Mady, Charles ^a   Krieger, José Eduardo ^a   Zugaib, Marcelo ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Clinical evolution; Hypertrophic cardiomyopathy; Maternal fetal evolution; Pregnancy

Indexed keywords

MYOSIN HEAVY CHAIN BETA;

ADULT; ARTICLE; CEREBROVASCULAR ACCIDENT; CESAREAN SECTION; CHROMOSOME 14; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL EXAMINATION; CONTROL GROUP; CONTROLLED STUDY; DISEASE COURSE; ELECTROCARDIOGRAM; FAMILY HISTORY; FEMALE; FETUS OUTCOME; GENE MUTATION; GENETIC ANALYSIS; HEART ARRHYTHMIA; HEART FAILURE; HOSPITALIZATION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; NEWBORN DEATH; OBSTETRICS; PREGNANCY; PREGNANT WOMAN; PREMATURITY; PROGENY; PROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; STILLBIRTH; TRANSTHORACIC ECHOCARDIOGRAPHY; CASE CONTROL STUDY; NEWBORN; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PROGNOSIS;

ADULT; CARDIOMYOPATHY, HYPERTROPHIC; CASE-CONTROL STUDIES; FEMALE; HUMANS; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREGNANCY OUTCOME; PROGNOSIS; PROSPECTIVE STUDIES;

EID: 34249981836     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Robson SC, Hunter S, Boys RJ, Dunlop W. Serial study of factors influencing changes in cardiac output during human pregnancy. Am J Physiol. 1989; 256 (4 Pt 2): H1060-5.
2. Maron B. Hypertrophic cardiomyopathy: a systematic review. JAMA. 2002; 287: 1308-20.
3. Elkayam U, Dave R. Hypertrophic cardiomyopathy and pregnancy. In: Elkayam U, Gleicher N. Cardiac Problems in Pregnancy: diagnosis and management of maternal and fetal heart disease 3rd edition. New York: Wiley-Liss, 1998; p. 211-21.
4. Van Kasteren YM, Kleinhout J Smit, Kleinhout J, Smit MA, Van Vugt JMG, van Geijn HP. Hypertrophic cardiomyopathy and pregnancy: a report of three cases. Eur J Obstet & Gynecol and Reprod Biol. 1990; 38: 63-7.
5. Shah DM, Sunderji SG, Hypertrophic cardiomyopathy and pregnancy: report of a maternal mortality and review of literature. Obstet Gynecol Surv. 1985; 40: 444-8.
6. Pellicia, F Cianfrocca, C Gaudio, Reale A. Sudden death during pregnancy in hypertrophic cardiomyopathy. Eur Heart J. 1992; 13: 421-3.
7. Autore C, Conte MR, Piccinino M, Bernabò P, Bonfiglio G, Bruzzi P, et al. Risk associated with pregnancy in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2002; 40; 1864-9
8. Avila WS, Grinberg M, Ramires RC, Arteaga E, Bortolotto MRL, Sampaio RO, Da Luz PL. Pregnancy in women with hypertrophic cardiomyopathy: maternal and fetal outcomes. Eur Heart J. 1998; 19:132.
9. Shah DM, Sunderji SG. Hypertrophic cardiomyopathy and pregnancy: report of a maternal mortality and review of literature. Obstet Gynecol. 1985; 40: 444-8.
10. Maron BJ. Hypertrophic cardiomyopathy. Lancet. 1997; 59: 689-706
11. Watkins H, MacKenna WJ, Thierfelder L. Mutations in the genes for cardiac troponin T and a-tropomyosin in hypertrophic cardiomyopathy. N Engl J Med. 1995: 332; 1058-64.
12. Maron BJ, Moller JH, Seidman CE, Vincent GM, Dietz HC, Moss AJ, et al. Impact of laboratory molecular diagnosis on contemporary diagnostic criteria for genetically transmitted cardiovascular diseases: hypertrophic cardiomyopathy, long-QT syndrome, and Marfan syndrome: a statement for healthcare professionals from councils on clinical cardiology, Cardiovascular disease in the young and basic science. American Heart Association. Circulation. 1998; 98 (14):1460-71.
13. Klues HG, Schiffers A, Maron BJ. Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients. J Am Coll Cardiol. 1995; 26:1699-708.
14. Panza JA, Petrone RK, Fananapazir L, Maron BJ. Utility of continuous wave Doppler echocardiography in the noninvasive assessment of left ventricular outflow tract pressure gradient in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 1992;19:91-9.
15. Spirit P, Seidman CE, MacKenna WJ, Maron BJ. Management of hypertrophic cardiomyopathy. N Engl J Med. 1997; 336: 775-85.
16. Maron BJ, Gardin JM, Gflack JM, Giddingm SS, Kurosaki TT, Bild DE. Prevalence of hypertrophic cardiomyopathy in the general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronay Artery Risk Development in (Young) Adults. Circulation. 1995; 92: 785-9.
17. Ávila WS, Rossi EG, Ramires JAF, Grinberg M, Bortolotto MR, Zugaib M, Da Luz PL. Pregnancy in patients with heart disease: experience with 1,000 cases. Clin Cardiol. 2003; 26: 135-42.
18. Oakley GDG, McGarry K, Limb DG, Oakley CM. Management of pregnancy in patients with hypertrophic cardiomyopathy. Br Med J. 1979; 1: 1749-50.
19. Benitez RM. Hypertrophic cardiomyopathy and pregnancy: maternal and fetal outcomes. J Matern Fetal Invest. 1996; 6: 51-5.
20. Olivotto I, Cecchi F, Casey AS, Dolara A Traverse JH, Maron BJ. Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy. Circulation. 2001; 104: 2517-24.
21. Maron MS, Olivotto I, Betocchi S, Casey SA, Lesser JR, Losi MA, et al. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. N Engl J Med. 2003; 348: 295-303
22. Rubin, PC. Beta blockers in pregnancy. N Engl J Med. 1981; 305: 1323-6.
23. Orlandi C, Marlettini MG, Cassani A. Treatment of hypertension during pregnancy with the calcium antagonist verapamil. Curr Therap Res. 1986; 39: 884-93.
24. Probst V, Langlard JM, Desnos M, Komajda M, Bouhour JB. Familial hypertrophic cardiomyopathy. French study of the duration and outcome of pregnancy. Arch Mal Coeur Vaiss. 2002; 95: 81-6.
25. Charron P, Carrier L, Dubourg O, Tesson F, Desnos M, Richard P, et al. Penetrance of familial hypertrophic cardiomyopathy. Genet Couns. 1997; 8 (2):107-14.
26. Maron BJ, Spirito P. Implications of left ventricular remodeling in hypertrophic cardiomyopathy. Am J Cardiol. 1998; 81:1339-44.
27. Suda, K Kohl, T Kovalchin, JP Silverman, NH. Echocardiographic predictors of poor outcome in infants with hypertrophic cardiomyopathy. Am J Cardiol. 1997; 80: 595-600.
28. Watkins H, Rosenzweig WH, Hwang DS, Levi T, MacKenna W, Seidman C, et al. Characteristics and prognostic implication of myosin missense mutations in familial hypertrophic cardiomyopathy. N Engl J Med. 1992; 326: 1108-14.